In a strategic accord forged in tandem with Flagship Pioneering, Novo Nordisk ha...
In response to the occurrence of two fatalities within its VX-880 diabetes drug ...
With the agreement to shell out $680 million for Harpoon Therapeutics and its on...
Bayer, the renowned pharmaceutical giant headquartered in Germany, has recently ...
Innovent, a prominent player in the Chinese pharmaceutical landscape, is gearing...
Curevo Vaccine’s bold strategic move to enter the competitive Shingles vaccine m...
AstraZeneca and Sanofi achieved a milestone as their respiratory syncytial virus...
Researchers have made a significant breakthrough in the fight against antibiotic...
Novartis announced an expansion of its collaborative efforts with Voyager Therap...
Swiss pharmaceutical company Roche announced its agreement to acquire LumiraDx’s...
Japanese pharmaceutical company Otsuka Pharmaceutical has entered into a signifi...
Gilead Sciences has concluded a significant transaction with Compugen, securing ...
Pivotal bioVenture Partners has successfully concluded its second fund, securing...
The ongoing surge of interest in antibody-drug conjugates (ADCs) remains unabate...
In less than a week following the submission of the historic first request for a...
Sanofi, a prominent figure in the pharmaceutical realm, finds itself grappling w...
